CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round ...
At BIO 2026 in San Diego, Contract Pharma spoke with Zara Asgharpour, Head of External Innovation Integrated Biologics at ...
A broad European industry/academic consortium, Inno4Vac, has developed a robust, open-source modeling platform that unifies upstream and downstream models and predicts product stability, all within a ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Photo: Christophe Gateau/dpa (Photo by Christophe Gateau/picture alliance via Getty Images) ...
@article{khurana2018deepsol, title={DeepSol: a deep learning framework for sequence-based protein solubility prediction}, author={Khurana, Sameer and Rawi, Reda and Kunji, Khalid and Chuang, Gwo-Yu ...
A hybrid modeling framework to optimize Chinese hamster ovary cell cultures for monoclonal antibody (mAb) production reduces the number of modeling parameters needed while returning results that ...
The Tesla Model Y’s midcycle refresh brought significant enough changes to earn it a spot in our 2026 SUV of the Year competition. The full list of updates is extensive, but the highlights matter.
Oct 14 (Reuters) - U.S. biotech firm Nabla Bio said on Tuesday it has signed a second major research partnership with Japanese drugmaker Takeda Pharmaceutical (4502.T), opens new tab, deepening their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results